Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03688672 · ClinicalTrials.gov registry record · NA

Apioc Contact Lens Feasibility

A NA study of Myopia and Presbyopia, sponsored by Lentechs.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03688672 is a NA study of Myopia and Presbyopia that has completed, run by Lentechs. The registered enrollment target is 50 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03688672, a NA study of Myopia and Presbyopia, has completed, sponsored by Lentechs.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This clinical trial will document the feasibility of the Apioc lens design by assessing which lens shape parameters yield successful on-eye-fit and movement of the Apioc contact lens design and evaluate the subjectively-reported comfort of the Apioc contact lens design.

Interventions

  • DEVICE Apioc Contact Lens Design

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-10-01
Est. Completion 2020-10-31
Phase NA

Sponsor

Lentechs

6 total trials

What the Registry Record Tells You About NCT03688672

The ClinicalTrials.gov registry entry for NCT03688672 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The listed sponsor is Lentechs, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Apioc Contact Lens Design is the first listed.

NCT03688672 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03688672 about?

NCT03688672 is a clinical study titled "Apioc Contact Lens Feasibility". This clinical trial will document the feasibility of the Apioc lens design by assessing which lens shape parameters yield successful on-eye-fit and movement of the Apioc contact lens design and evaluate the subjectively-reported comfort of the Apioc contact lens design.

What is the current status of trial NCT03688672?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-10-01. Estimated completion is 2020-10-31.

What conditions does trial NCT03688672 study?

This clinical trial studies the following conditions: Myopia, Presbyopia, Astigmatism, Hyperopia, Ametropia.

What interventions are being tested in trial NCT03688672?

The interventions under investigation include: Apioc Contact Lens Design (DEVICE).

Who is sponsoring clinical trial NCT03688672?

This trial is sponsored by Lentechs, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03688672 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.